1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with a 85783.0 in 4 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (a 85783.0) | Trials (a 85783.0) | Recent Studies (post-2010) (a 85783.0) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 6 | 1 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albert, DH; Carter, GW; Conway, RG; Davidsen, SK; Holms, JH; Luo, G; Magoc, TJ; Rhein, DA; Summers, JB; Tapang, P | 1 |
| Albert, DH; Carter, GW; Kleinert, HD; Magoc, TJ; Menacherry, SD; Morgan, DW; Reyes, AE; Summers, JB; Sun, E | 1 |
| Hood, AF; Morin, SM; Pei, Y; Travers, J | 1 |
| Chang, KH; Jeon, EJ; Kim, DH; Lee, SK; Park, YS; Yeo, SW | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and a 85783.0
| Article | Year |
|---|---|
Ex vivo inhibition of beta-thromboglobulin release following administration to man of ABT-299, a novel prodrug of a potent platelet activating factor antagonist.
Topics: Adolescent; Adult; beta-Thromboglobulin; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Double-Blind Method; Humans; In Vitro Techniques; Indoles; Injections, Intravenous; Male; Platelet Activating Factor; Platelet Aggregation Inhibitors; Prodrugs; Pyridinium Compounds; Thiazoles | 1997 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and a 85783.0
| Article | Year |
|---|---|
ABT-299, a potent antagonist of platelet activating factor.
Topics: Animals; Binding, Competitive; Blood Pressure; Edema; Esterases; Humans; Hypotension; Indoles; Kinetics; Lipopolysaccharides; Mice; Molecular Structure; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prodrugs; Pyridinium Compounds; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Shock, Septic; Thiazoles | 1995 |
Antiinflammatory activity of the platelet-activating factor receptor antagonist A-85783.
Topics: Animals; Anti-Inflammatory Agents; Ear; Indoles; Inflammation; Male; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Skin; Thiazoles | 1998 |
Effects of tumor necrosis factor alpha antagonist, platelet activating factor antagonist, and nitric oxide synthase inhibitor on experimental otitis media with effusion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Capillary Permeability; Ear, Middle; Enzyme Inhibitors; Etanercept; Immunoglobulin G; Immunohistochemistry; Indoles; Injections, Intralesional; Injections, Intraperitoneal; Lipopolysaccharides; Multivariate Analysis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Otitis Media with Effusion; Photomicrography; Platelet Activating Factor; Pseudomonas aeruginosa; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor; Thiazoles; Tumor Necrosis Factor-alpha; Tympanic Membrane | 2006 |